These results suggest that the treatment of ALL REH and MOLT-4 cells with studied inhibitors affects the reduction of NF-κB protein level, which in turn decreases antioxidant protein levels, such as NRF2/HO-1 and TrxR, and leads to the excessive generation of ROS. This evidence concerns the gene NFE2L2 and acute lymphoblastic leukemia.